BIOHEART-B: IBERIS® RDN system registered in the UK

Zhitong
2025.10.30 14:16
portai
I'm PortAI, I can summarize articles.

BIOHEART-B announced that its subsidiary Antong's Iberis® RDN system has been registered with the MHRA in the UK. This system is the only renal denervation product approved for use via the radial artery and femoral artery access globally. Antong has reached a strategic cooperation with Baisheng International Group, planning to promote this product in multiple regions, with the ultimate goal of providing outpatient RDN procedures for patients worldwide